$SVA News
Last published 2mo ago
- 2mo agoSVASINOVAC Reports Unaudited First Half of 2026 Financial ResultsBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited financial results for the six months
- 3mo agoSVASINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash DividendBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee
- 4mo agoSVASINOVAC Regained Compliance With the Nasdaq Global Market's Listing RequirementsBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the
- 5mo agoSVASINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-FBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31,
- 5mo agoSVASINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual ReportBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the "Notification
- 5mo agoSVASINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash DividendBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit
- 6mo agoSVASINOVAC Reports Unaudited First Half of 2025 Financial ResultsBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2025. First
- 6mo agoSVASINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024Business WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December
- 10mo agoSVASINOVAC Provides Update on Antigua High Court Order and Auditor EngagementBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court's interlocutory order governing the Company's
- 10mo agoSVASinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year ReportBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the
- 10mo agoSVASinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder MeetingBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr. Simon Anderson, Mr.
- 11mo agoSVASINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to AppealBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting determination letter (the
- 1y agoSVAIndependent Sinovac Shareholders Express Strong Support for Immediate Dividend PaymentPR NewswireSinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent...
- 1y agoSVASINOVAC Announces Appointment of Independent AuditorBusiness WireCritical step in improving transparency and resuming trading on NASDAQ The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical
- 1y agoSVASINOVAC Board Sets the Record Straight on July 8 Special Meeting of ShareholdersBusiness WireSpecial Meeting validly adjourned until the appropriate court makes a final decision on validity of the PIPE shares and will be reconvened SAIF and the Dissenting Investor Group's deceptive claims of a "continuation
- 1y agoSVANewly Elected Directors of Sinovac Hold the First Board MeetingBusiness WireMr. Andrew Y. Yan elected Chairman of the Board New Board Unanimously Resolved to Explore Future Dividend Plans, Conduct Search for New Auditor for Resuming NASDAQ Trading, and Restore Stable Operations of the
- 1y agoSVASINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former BoardBusiness WireSpecial Meeting was validly adjourned until the appropriate court can make a final decision on the validity of the PIPE shares SAIF's "announcement" about voting results demonstrates blatant disregard for the law and
- 1y agoSVASINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend PaymentBusiness WireSpecial cash dividend is being paid to valid common shareholders who owned SINOVAC as of the close of business on July 7, 2025 Board will continue to prioritize dividend distributions according to its previously
- 1y agoSVASINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE SharesBusiness WireOn July 7 Antigua Court restricted PIPE shares from voting in Special Shareholder Meeting, but Eastern Caribbean Court of Appeal granted a temporary stay of the injunction shortly before Special Meeting 2018 PIPE
- 1y agoSVASinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special MeetingBusiness WireShareholders Voted to Approve Both SAIF Partners Proposals at Special Meeting Newly Elected Directors Are Committed to Support and Execute the Announced Payout of Dividends and Unlock Sinovac's Long-Term Value for All
- 1y agoSVAAppeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder VoteBusiness WireDecision Stays Attempt of 1Globe to Disenfranchise Shareholders Vivo Capital ("Vivo" or "we"), a leading global investment firm focused exclusively on healthcare and life sciences and a long term shareholder of
- 1y agoSVAFinal Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2Business WireSINOVAC's Board of Directors encourages shareholders to follow recommendations of leading independent proxy advisory firms ISS and Glass Lewis and VOTE to KEEP the Current Board in Place VOTE as soon as possible –
- 1y agoSVAFederal Court in Massachusetts Denies Vivo Capital's Petition for Relief on SINOVACBusiness WireCourt denies Vivo Capital's petition for relief relating to shareholder votes and corporate governance, clearing another legal hurdle for distribution of the US$55.00 per common share special cash dividend Marks
- 1y agoSVALeading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in PlaceBusiness WireISS states, "[T]he [current] board appears to be working to pay SVA shareholders their fair share of dividends, and to resume trading of the company's shares, which are the two most pressing issues currently facing
- 1y agoSVAUnited States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding SinovacBusiness WireCourt Found That 1Globe and Li Likely Violated Disclosure Obligations; Mandates Both File Updated Disclosures Within 5 Days of Order Decision Cites Prolonged Pattern of Corruption and Deception by 1Globe and Li Vivo
- 1y agoSVASAIF Partners: Now is Your Last Chance to Vote for Board Change at SinovacBusiness WireSinovac's Special Meeting of Shareholders is Just Days Away; Your Vote Matters No Matter How Many Shares You Own SAIF Partners Urges Shareholders to Vote the GOLD Proxy Card "FOR" its Director Candidates to End Years
- 1y agoSVALeading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in PlaceBusiness WireGlass Lewis concludes, "[T]he current board has demonstrated credible progress in restoring governance stability and operational normalcy. [...] The Dissident Group's proposals, by contrast, rest on an inconsistent
- 1y agoSVASAIF Partners Sends Letter to Sinovac ShareholdersBusiness WireHighlights Current Board's Empty Promises, Failure to Deliver Value for Shareholders, and Certain Directors' Concerning Patterns of Reckless, Unethical and Illegal Actions to Retain Control of Sinovac SAIF Partners
- 1y agoSVASINOVAC Board of Directors Urges Shareholders to Vote the WHITE Proxy Card "AGAINST" the Misguided Proposals to Remove SINOVAC's Current BoardBusiness WireReaffirms Commitment to Declaring Dividends and New Dividend Policy Underscores Pledge to Work with NASDAQ Toward Resuming Trading Continues to Diligently Defend Against the Dissenting Investor Group's
- 1y agoSVASINOVAC Board of Directors Prevails Against Advantech/Prime's Lawsuit in Hong KongBusiness WireHong Kong Court denies Advantech/Prime's petition for Interim Relief Clears another legal hurdle for distribution of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board to be paid
- 1y agoSVASAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board's Failure to Act in the Interests of ShareholdersBusiness WireSAIF Partners Nominees Will Work Proactively to Help Shareholders Realize Full Value of Sinovac, Including Through the Payment of Significant Dividends and Resumption of Trading of Common Shares Current Board – With
- 1y agoSVASINOVAC Board of Directors Files Investor Presentation Outlining Decisive Actions to Protect Shareholder InterestsBusiness WireHighlights bold steps to restore fairness to SINOVAC's common shareholders and deliver long-term value creation Urges shareholders to VOTE the WHITE proxy card "AGAINST" the misguided proposals to remove SINOVAC's
- 1y agoSVAPrime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special MeetingBusiness WireCorrects the Record Following Latest Attempt By the 1Globe Activist Board to Distort Reality in Transparent Attempt to Mislead Shareholders Notes That on Friday Antiguan Judge Denied the 1Globe Activist Board's
- 1y agoSVASINOVAC Board of Directors Prevails Against Advantech/Prime's New York LawsuitBusiness WireNew York Court Denies Advantech/Prime's Petition for Emergency Injunctive Relief Clears Legal Hurdle for Dividend Paying Agent to Payout the Special Cash Dividend of US$55.00 Per Common Share on July 7, 2025 SINOVAC
- 1y agoSVASINOVAC Board of Directors Files Definitive Proxy MaterialsBusiness WireFiles definitive proxy statement and mails letter to shareholders Urges shareholders to VOTE the WHITE proxy card and vote "AGAINST" the misguided proposals to remove SINOVAC's Board and appoint the Reconstituted
- 1y agoSVASINOVAC Announces New Board MemberBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang, a member of the
- 1y agoSVASINOVAC Board of Directors Provides Update on Special Dividend Payment and Commitment to Delivering Value to All ShareholdersBusiness WireAccelerates payment of previously announced special cash dividend of US$55.00 per common share Decides to declare second special cash dividend of US$19.00 per common share Intends to declare third special cash
- 1y agoSVAPrime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech's Current BoardBusiness WirePrime Success L.P., (together with its affiliates, "Prime Success" or "we"), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company") with ownership of approximately 8% of the
- 1y agoSVASAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the BoardBusiness WireSends Open Letter to Sinovac Shareholders Calling for a New Board to End Years of Chaos at Sinovac SAIF Nominees Will Work to Resolve Costly Legal Battles, Take Action to Resume Stock Trading after Six-Year Halt, and
- 1y agoSVAHeng Ren Calls on Sinovac to Pay Shareholders the Special Dividend Before the July 8 Board VotePR NewswireSinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today sent an open resolution to Sinovac's shareholders outlining...
- 1y agoSVAHeng Ren Calls on Sinovac to Pay Shareholders the Special Dividend Before the July 8 Board VotePR NewswireSinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today sent an open resolution to Sinovac's shareholders outlining...
- 1y agoSVASINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid ShareholdersBusiness WireVivo Capital Challenges SINOVAC's Paying Agent on Distribution of the Dividend Opposition Brief to be Filed Monday in Advance of Wednesday Hearing and Expected Friday Decision The Board of Directors of SINOVAC
- 1y agoSVAPrime Success Responds to Sinovac Biotech's False and Misleading ClaimsBusiness WireFor More Information, Visit www.SaveSinovac.com Prime Success L.P., (together with its affiliates, "Prime Success" or "we"), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company")
- 1y agoSVASINOVAC's Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All ShareholdersBusiness WireIntends to file definitive proxy materials in the coming days Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it intends
- 1y agoSVAVivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company's False and Misleading ClaimsBusiness WireAffirms Support for Fair and Equitable Dividend Distribution for All Shareholders by Sinovac Corrects the Company's Misrepresentations of Vivo's Capital Contributions, Which Have Been Critical to Sinovac's Commercial
- 1y agoSVAPrime Success Sends Letter to Sinovac Biotech ShareholdersBusiness WireDetails Why Change is Needed on Sinovac's Board in Order to Restore Company's Previous Success and Reverse Value-Destructive Path Taken Under Current Board Affirms Commitment to Seeing Company Reinstate Trading on the
- 1y agoSVASINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual ReportBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 16, 2025 (the "Notification
- 1y agoSVASINOVAC Announces Record and Distribution Dates for Special Cash DividendBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on
- 1y agoSVASINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo CapitalBusiness WireSinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the "Board") issued a public letter to shareholders
- 1y agoSVAVivo Capital Files Lawsuits to Protect Sinovac Shareholders from the New Board's Value Destructive ActionsBusiness WireFollows Announcement by Sinovac Management Team That External Auditor Resigned Due to Unreliability of Current Board Vivo Capital ("Vivo" or the "Firm"), a leading global investment firm focused exclusively on